Prabhat Ghanshyam Bhargava

26PUBLICATIONS
101CO-AUTHORS
Predictive and prognostic markersSurgeryCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Sep 30, 2026
Early clinical outcomes, treatment adherence, and toxicity profile of adjuvant CDK4/6 inhibitors in hormone receptor-positive early breast cancer: Real-world data from India.

|May 06, 2026
Surgical Management of Recurrent Retroperitoneal Sarcomas: Experience From a High-Volume Sarcoma Centre: Recurrent Retroperitoneal Sarcomas: Outcomes of Multiple Recurrences.

|Apr 07, 2026
Development and Validation of Nomogram Predicting Survival in Resectable Gallbladder Cancer.

Shraddha Patkar, Tanvi M Shah, Mufaddal Kazi

|Mar 11, 2026
Carica Papaya Leaf Extract to Improve Chemotherapy-Induced Thrombocytopenia: A Phase III Triple-Blinded, Randomized, Placebo-Controlled, Multicentric Trial.

Vikas Ostwal, Manali Parulekar, Deepali Naughane

|Jan 28, 2026
Efficacy and Safety of Ultra-Low-Dose Immunotherapy in Relapsed Refractory Solid Tumors: Phase III Superiority Randomized Trial (DELII).

Vanita Noronha, Vijay Patil, Nandini Menon

|Dec 31, 2025
Practice Patterns and Incidence of F ebrile Neutr o penia in Patients R eceiving T riplet Drug Chemotherapeutic Regimens in G U T Cancers: Do We Need to Add WBC Growth Factors? (ForGeT GCSF Study).

Kapu Venkatesh, Anant Ramaswamy, Noorzia Sultana

Pageof 5

Frequent Collaborators

15 joint publications

Vikas S Ostwal

9 joint publications

Anant Ramaswamy

7 joint publications

Sudeep Gupta

5 joint publications

Sujay Srinivas